The response to vedolizumab in chronic granulomatous disease-related inflammatory bowel disease.
Natasha KamalBeatriz MarcianoBryan CurtinAnna StronginSuk See DeRavinAthos BousvarosChristopher KohHarry L MalechSteven M HollandChrista ZerbeTheo HellerPublished in: Gastroenterology report (2020)